![Michael Lewis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Michael E.
Lewis was the founder of Cephalon LLC, founded in 1988, serving as Senior Director-Scientific Affairs in 1993.
Dr. Lewis is the founder of Adolor Corp., founded in 1994.
Dr. Lewis was the founder of Arena Pharmaceuticals, Inc., founded in 1997, serving as Director in 2000.
Dr. Lewis was the founder of CARA Therapeutics, Inc., founded in 2004, serving as Director & Chief Scientific Advisor from 2010 to 2011.
Dr. Lewis is also the founder of Oban Biopharma, Inc...
Dr. Lewis is currently Director at PolyMedix Pharmaceuticals, Inc. since 2002.
Dr. Lewis is currently President at BioDiligence Partners, Inc. since 1994.
Dr. Lewis was Director at Incara Pharmaceuticals Corp.
Dr. Lewis was Independent Director at PolyMedix, Inc. from 2005 to 2013.
Dr. Lewis was Independent Director at Aeolus Pharmaceuticals, Inc. from 2011 to 2013.
Dr. Lewis was Vice President-Research at Message Pharmaceuticals, Inc. in 1994.
Dr. Lewis completed undergraduate studies at George Washington University.
Dr. Lewis earned graduate and doctorate degrees from Clark University in 1977.
Actieve functies van Michael Lewis
| Bedrijven | Functie | Begin |
|---|---|---|
PolyMedix Pharmaceuticals, Inc. | Directeur/Bestuurslid | 01-08-2002 |
BioDiligence Partners, Inc. | President | 01-01-1994 |
Eerdere bekende functies van Michael Lewis
| Bedrijven | Functie | Einde |
|---|---|---|
| AEOLUS PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 08-05-2013 |
| POLYMEDIX, INC. | Directeur/Bestuurslid | 29-03-2013 |
Incara Pharmaceuticals Corp.
 Incara Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cardiovascular and pulmonary diseases | Directeur/Bestuurslid | 09-08-2004 |
| ARENA PHARMACEUTICALS | Oprichter | 01-01-2000 |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Oprichter | - |
Opleiding van Michael Lewis
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
48
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Incara Pharmaceuticals Corp.
Incara Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cardiovascular and pulmonary diseases | Health Technology |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
PolyMedix, Inc.
 PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic small molecule compound drugs | Health Technology |
CARA Therapeutics, Inc.
 CARA Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes new chemical entities designed to fundamentally change the way acute pain, chronic pain and pruritus are managed | Health Technology |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aeolus Pharmaceuticals, Inc.
 Aeolus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Clark University
 Clark University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Message Pharmaceuticals, Inc.
 Message Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
PolyMedix Pharmaceuticals, Inc. | |
BioDiligence Partners, Inc. |
